126 related articles for article (PubMed ID: 9172948)
1. Microbial models of mammalian metabolism. Fungal metabolism of phenolic and nonphenolic p-cymene-related drugs and prodrugs. II. Metabolites of nonphenolic derivatives.
Moussa C; Houziaux P; Danree B; Azerad R
Drug Metab Dispos; 1997 Mar; 25(3):311-6. PubMed ID: 9172948
[TBL] [Abstract][Full Text] [Related]
2. Microbial models of mammalian metabolism. Fungal metabolism of phenolic and nonphenolic p-cymene-related drugs and prodrugs. I. Metabolites of thymoxamine.
Moussa C; Houziaux P; Danree B; Azerad R
Drug Metab Dispos; 1997 Mar; 25(3):301-10. PubMed ID: 9172947
[TBL] [Abstract][Full Text] [Related]
3. Biotransformations of the cardiovascular drugs mexrenone and canrenone.
Preisig CL; Laakso JA; Mocek UM; Wang PT; Baez J; Byng G
J Nat Prod; 2003 Mar; 66(3):350-6. PubMed ID: 12662091
[TBL] [Abstract][Full Text] [Related]
4. Microbial transformation of the antihistamine pyrilamine maleate. Formation of potential mammalian metabolites.
Hansen EB; Cerniglia CE; Korfmacher WA; Miller DW; Heflich RH
Drug Metab Dispos; 1987; 15(1):97-106. PubMed ID: 2881765
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo evaluations of the metabolism, pharmacokinetics, and bioavailability of ester prodrugs of L-767,679, a potent fibrinogen receptor antagonist: an approach for the selection of a prodrug candidate.
Prueksaritanont T; Gorham LM; Breslin MJ; Hutchinson JH; Hartman GD; Vyas KP; Baillie TA
Drug Metab Dispos; 1997 Aug; 25(8):978-84. PubMed ID: 9280406
[TBL] [Abstract][Full Text] [Related]
6. Microbial biotransformations of a synthetic immunomodulating agent, HR325.
Lacroix I; Biton J; Azerad R
Bioorg Med Chem; 1997 Jul; 5(7):1369-80. PubMed ID: 9377097
[TBL] [Abstract][Full Text] [Related]
7. Biotransformation of metoprolol by the fungus Cunninghamella blakesleeana.
Ma B; Huang HH; Chen XY; Sun YM; Lin LH; Zhong DF
Acta Pharmacol Sin; 2007 Jul; 28(7):1067-74. PubMed ID: 17588344
[TBL] [Abstract][Full Text] [Related]
8. Microbial transformations of aryltetralone and aryltetralin lignans by Cunninghamella echinulata and Beauveria bassiana.
Messiano GB; Wijeratne EM; Lopes LM; Gunatilaka AA
J Nat Prod; 2010 Nov; 73(11):1933-7. PubMed ID: 20961092
[TBL] [Abstract][Full Text] [Related]
9. Fungal metabolism of 4-substituted amphetamines.
Foster BC; Nantais LM; Wilson DL; By AW; Zamecnik J; Lodge BA
Xenobiotica; 1990 Jun; 20(6):583-90. PubMed ID: 2219953
[TBL] [Abstract][Full Text] [Related]
10. Biotransformation of indomethacin by the fungus Cunninghamella blakesleeana.
Zhang P; Lin LH; Huang HH; Xu HY; Zhong DF
Acta Pharmacol Sin; 2006 Aug; 27(8):1097-102. PubMed ID: 16867265
[TBL] [Abstract][Full Text] [Related]
11. Design of new dopamine D2 receptor ligands: biosynthesis and pharmacological evaluation of the hydroxylated metabolite of LASSBio-581.
Pazini F; Menegatti R; Sabino JR; Andrade CH; Neves G; Rates SM; Noël F; Fraga CA; Barreiro EJ; de Oliveira V
Bioorg Med Chem Lett; 2010 May; 20(9):2888-91. PubMed ID: 20363131
[TBL] [Abstract][Full Text] [Related]
12. Biosynthesis of human diazepam and clonazepam metabolites.
de Paula NC; Araujo Cordeiro KC; de Melo Souza PL; Nogueira DF; da Silva e Sousa DB; Costa MB; Noël F; de Oliveira V
Bioorg Med Chem Lett; 2015 Mar; 25(5):1026-9. PubMed ID: 25655722
[TBL] [Abstract][Full Text] [Related]
13. Biotransformation of valdecoxib by microbial cultures.
Keshetti S; Ciddi V
J Microbiol Biotechnol; 2010 Apr; 20(4):809-16. PubMed ID: 20467258
[TBL] [Abstract][Full Text] [Related]
14. Application of biocatalysis to drug metabolism: preparation of mammalian metabolites of a biaryl-bis-sulfonamide AMPA (alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid) receptor potentiator using Actinoplanes missouriensis.
Zmijewski M; Gillespie TA; Jackson DA; Schmidt DF; Yi P; Kulanthaivel P
Drug Metab Dispos; 2006 Jun; 34(6):925-31. PubMed ID: 16507647
[TBL] [Abstract][Full Text] [Related]
15. Microbial models of mammalian metabolism: microbial transformation of naproxen.
el Sayed KA
Pharmazie; 2000 Dec; 55(12):934-6. PubMed ID: 11189871
[TBL] [Abstract][Full Text] [Related]
16. Microbial metabolism. Part 12. Isolation, characterization and bioactivity evaluation of eighteen microbial metabolites of 4'-hydroxyflavanone.
Mikell JR; Herath W; Khan IA
Chem Pharm Bull (Tokyo); 2011; 59(6):692-7. PubMed ID: 21628902
[TBL] [Abstract][Full Text] [Related]
17. Self-immolative nitrogen mustard prodrugs for suicide gene therapy.
Niculescu-Duvaz D; Niculescu-Duvaz I; Friedlos F; Martin J; Spooner R; Davies L; Marais R; Springer CJ
J Med Chem; 1998 Dec; 41(26):5297-309. PubMed ID: 9857097
[TBL] [Abstract][Full Text] [Related]
18. Metabolism of (R)-(+)-pulegone in F344 rats.
Chen LJ; Lebetkin EH; Burka LT
Drug Metab Dispos; 2001 Dec; 29(12):1567-77. PubMed ID: 11717176
[TBL] [Abstract][Full Text] [Related]
19. Microbial transformations of natural antitumor agents. IV. Formation of N-(2)-nor-d-tetrandrine by Cunninghamella blakesleeana (ATCC 8688a).
Davis PJ; Wiese DR; Rosazza JP
Lloydia; 1977; 40(3):239-46. PubMed ID: 895382
[TBL] [Abstract][Full Text] [Related]
20. Repression of reserve lipid turnover in Cunninghamella echinulata and Mortierella isabellina cultivated in multiple-limited media.
Papanikolaou S; Sarantou S; Komaitis M; Aggelis G
J Appl Microbiol; 2004; 97(4):867-75. PubMed ID: 15357737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
